ライフサイエンスコーパス: Hispanic

1 found interactions of haplotypes with race (Hispanic).

2 e, 17.4% as non-Hispanic black, and 14.6% as Hispanic.

3 is 31% black non-Hispanic and 65% white non-Hispanic.

4 ge was 57 years, 65% were male, and 28% were Hispanic.

5 tional age, 70.0% were white, and 48.1% were Hispanic.

6 black non-Hispanic, and 29.6% were white non-Hispanic.

7 78 (40%) were black, and 31 of 85 (36%) were Hispanic.

8 of 4.9 years; 32.3% were women and 9.7% were Hispanic.

9 5% were female, 32% were Black, and 15% were Hispanic.

10 ere women, 25.5% African American, and 64.0% Hispanic.

11 e female, and 75.4% were African-American or Hispanic.

12 were non-Hispanic Black (Black), and 7% were Hispanic.

13 es being greater for non-Hispanic blacks and Hispanics.

14 flare events within 5 km as those with <20% Hispanics.

15 d 68,377 for NHW, 29,476 for NHB, 23,256 for Hispanic, 1,143 for NHAIAN, and 6,468 for NHAPI populati

16 o: 0.91 [95% CI, 0.90-0.93]) was lower among Hispanics (13.2%) and non-Hispanic blacks (13.6%) compar

17 Meth-ICH was more common in Hispanics (14.6%) and Whites (10.1%) as compared to Asia

18 itive (68%), Black/African-American (68%) or Hispanic (16%), and low income (48% reported <$12,000/y)

19 or NHB, 2.8 (95% CI 2.7, 3.0; p < 0.001) for Hispanic, 2.2 (95% CI 1.8, 2.6; p < 0.001) for NHAIAN, a

20 rates of MBS utilization (45.8%) compared to Hispanics (22.7%) and non-Hispanic blacks 14.2% (P = .00

21 ients hospitalized with COVID-19, 33.0% were Hispanic, 25.5% were non-Hispanic Black, 6.3% were Asian

22 00 individuals: 60.0, 95% CI 59.6-60.5) than Hispanic (52.7, 95% CI 52.1-53.4) and White individuals

23 (39 vs 57 yr old, respectively; p < 0.0001), Hispanic (83%; p < 0.0001), and uninsured (87%; p < 0.00

24 we studied 35 900 donors (70.3% white, 14.5% Hispanic, 9.3% black, 4.4% Asian) to understand the incr

25 genetic impact on circulating metabolites in Hispanics, a population with high cardiometabolic diseas

26 Hispanic (adjusted odds ratio [aOR] 0.72; P < .001) and

27 5.3%, non-Hispanic Asian adults; and 26.1%, Hispanic adults.

28 contemporary population-based studies of non-Hispanic African American and white adults aged 40-75 ye

29 pathogenic/P variants were identified in Non-Hispanic African ancestry probands.

30 ategories in men, women, Whites, Blacks, and Hispanics (all P<0.001).

31 , one locus in African Americans, and one in Hispanic Americans.

32 ean ancestry, 2702 African ancestry, and 360 Hispanic ancestry participants.

33 ispanic white ancestry, 5,971,598 (23.3%) of Hispanic ancestry, and 3,417,456 (13.34%) of non-Hispani

34 e Ochsner Health population is 31% black non-Hispanic and 65% white non-Hispanic.

35 entiation 4-positive) Th cells from 59 obese Hispanic and African American children with asthma and 6

36 an children with asthma and 61 normal-weight Hispanic and African American children with asthma under

37 e/ethnicity but increased by 38% and 29% for Hispanic and black >=50.

38 Most respondents identified as white, non-Hispanic and male.

39 included hypertension, obesity, female sex, Hispanic and non-Hispanic black ethnicity, worse glycemi

40 clined from 2009 to 2019, particularly among Hispanic and non-Hispanic Black women and in younger wom

41 Rates were also higher in Hispanic and white females and black and white males.

42 ity in testing positive for COVID-19 between Hispanic and White individuals was consistent across reg

43 valence of youth severe obesity increased in Hispanics and non-Hispanic blacks (P-trend < .001), but

44 ses, 60.0% were female, 70.4% were black non-Hispanic, and 29.6% were white non-Hispanic.

45 missing data on race or ethnic group, 9 were Hispanic, and 52 were Asian or of another race or ethnic

46 (from here referred to as Black), 14.9% were Hispanic, and 62.4% were non-Hispanic White (from here r

47 (range, 38-97 years); 69% were men, 57% were Hispanic, and 73% had a history of hypertension.

48 s best predicted IBD status in European, AJ, Hispanic, and African American cohorts in BioMe.

49 10%, and 12% of excess strokes among black, Hispanic, and Asian patients, respectively.

50 by lower use of anticoagulants among black, Hispanic, and Asian patients.

51 eviously unscreened African American, white, Hispanic, and Asian/Pacific Islander health plan members

52 on-Hispanic White (NHW), non-Hispanic Black, Hispanic, and the 7 largest Asian American populations.

53 rs; 29% were female, 11% were Black, 7% were Hispanic, and the median ejection fraction was 32%.

54 Among Black, Hispanic, and White patients with heart failure and redu

55 n whites, 6.6% in African Americans, 7.8% in Hispanics, and 9.9% in Chinese and was significantly low

56 iously unscreened African Americans, whites, Hispanics, and Asian/Pacific Islanders who were 51-56 ye

57 Blacks, Hispanics, and Asians had substantially lower frequencie

58 sks of mortality were also lower for blacks, Hispanics, and Asians.

59 xclusion of Blacks/African-Americans, Latinx/Hispanics, and Indigenous people from science has result

60 ins were largest in young adults, blacks and Hispanics, and lower-income Americans.

61 Eastern/Mediterranean (ME/M), and 48 (2.7%) Hispanic; and 1128 (64%) male.

62 le and older age groups; whites, blacks, and Hispanics; and the socioeconomically disadvantaged.

63 own race or race other than white, black, or Hispanic (aOR, 1.97 [1.42-2.74]), and uninsured patients

64 Our findings suggest Hispanics are disproportionately exposed to flares in th

65 The networks of Asians and Hispanics are sparse.

66 ative Americans, Alaska Natives, Asians, and Hispanics, as well as among native-born and unmarried in

67 21.6%, non-Hispanic Black adults; 5.3%, non-Hispanic Asian adults; and 26.1%, Hispanic adults.

68 mortality rates for these groups and the non-Hispanic Asian or Pacific Islander (NHAPI) population.

69 Racial disparity was observed with Hispanics, Asians and Pacific Islanders, and Native Amer

70 African American [AUC, 0.84], and white, non-Hispanic [AUC, 0.76] in a 5-class classifier), and a net

71 al/ethnic disparities in PBDE exposures (Non-Hispanic Black > Latina/Hispanic > Non-Hispanic White >

72 ere non-Hispanic White (White), 19% were non-Hispanic Black (Black), and 7% were Hispanic.

73 ients included in this study, 22.7% were non-Hispanic Black (from here referred to as Black), 14.9% w

74 Non-Hispanic black (NHB) and Hispanic patients have lower ac

75 Non-Hispanic black (versus non-Hispanic white) race/ethnicit

76 that controlled BP was less likely among non-Hispanic Black adults vs non-Hispanic White adults (41.5

77 % were non-Hispanic White adults; 21.6%, non-Hispanic Black adults; 5.3%, non-Hispanic Asian adults;

78 anic ancestry, and 3,417,456 (13.34%) of non-Hispanic black ancestry.

79 Residents of non-Hispanic Black and Hispanic neighbourhoods experienced h

80 nsion, obesity, female sex, Hispanic and non-Hispanic black ethnicity, worse glycemic control, and el

81 s; however, its prevalence is highest in non-Hispanic black individuals (BL) relative to other popula

82 Non-Hispanic Black pregnant women and women from Southern Ce

83 2019 to 2009, 0.14 [95% CI, 0.07-0.28]), non-Hispanic Black women (odds ratio, 0.31 [95% CI, 0.19-0.4

84 to 2019, particularly among Hispanic and non-Hispanic Black women and in younger women (in whom primo

85 gher levels of BDE-100 and BDE-153 among non-Hispanic Black women compared to the referent group (Lat

86 he greatest declines in disparities (for non-Hispanic black women, RR = 1.23, 95% CI: 1.18, 1.28; for

87 OVID-19, 33.0% were Hispanic, 25.5% were non-Hispanic Black, 6.3% were Asian, and 35.2% were non-Hisp

88 mean age was 49.4 years, 64% women were non-Hispanic black, 67% were former or current smokers, and

89 The 765 enrolled participants were 43% non-Hispanic black, 73% male, with a median age of 48 years;

90 e, 62.1% as non-Hispanic white, 17.4% as non-Hispanic black, and 14.6% as Hispanic.

91 , individuals who lacked insurance, were non-Hispanic black, had low income, or had high-comorbidity

92 omic sites for non-Hispanic White (NHW), non-Hispanic Black, Hispanic, and the 7 largest Asian Americ

93 .1% were female, and 41.9% identified as non-Hispanic black, with a mean age of 57.7 years, and the m

94 h beta-cell functions and incident DM in non-Hispanic, Black women with HIV and alters the relationsh

95 White or non-Hispanic versus non-White (ie, Hispanic, Black, Asian, or other).

96 ]) was lower among Hispanics (13.2%) and non-Hispanic blacks (13.6%) compared with non-Hispanic white

97 evere obesity increased in Hispanics and non-Hispanic blacks (P-trend < .001), but non-Hispanic white

98 45.8%) compared to Hispanics (22.7%) and non-Hispanic blacks 14.2% (P = .006).

99 as, with these changes being greater for non-Hispanic blacks and Hispanics.

100 males in comparison with females and for non-Hispanic Blacks in comparison with non-Hispanic Whites.

101 h disparities in mortality persisted for non-Hispanic Blacks versus non-Hispanic Whites (mean annual

102 tumor (NAT) samples collected from Black non-Hispanic (BNH) and White non-Hispanic (WNH) women.

103 have higher ESKD incidence compared with non-Hispanics, but little is known about the CKD incidence i

104 om 218 cases and 177 controls were Caribbean Hispanic (CH).

105 ldren appears to be more common in Black and Hispanic children in the United States.

106 opulations (mean 1,102 persons), and serving Hispanic communities (38.3%).

107 tions, located in the Southwest, and serving Hispanic communities were more likely to continue exceed

108 ardiopulmonary resuscitationtraining need in Hispanic communities.

109 on of Hispanics/Latinos participating in the Hispanic Community Health Study/Study of Latinos (HCHS/S

110 We included 2010 participants of the Hispanic Community Health Study/Study of Latinos (HCHS/S

111 from 1506 adults aged 18 to 64 years in the Hispanic Community Health Study/Study of Latinos ECHO-SO

112 yses on 640 circulating metabolites in 3,926 Hispanic Community Health Study/Study of Latinos partici

113 We included 7280 participants of the Hispanic Community Health Study/Study of Latinos who age

114 Using genotype data from the Hispanic Community Health Study/Study of Latinos, we fin

115 onset CKD using data from 8774 adults in the Hispanic Community Health Study/Study of Latinos.

116 of relatively older (>=45 years), white non-Hispanic decedents (corrected p = 0.014, n = 42).

117 white donors increased by 18%, 14%, and 27%; Hispanic donors <35 did not change but increased by 22%

118 vidence that the bar for searching black and Hispanic drivers was lower than that for searching white

119 1.26, 95% CI 1.05-1.52) vs. White race, and Hispanic ethnicity (aOR 1.52, 95% CI 1.40-1.65).

120 their validity in African ancestry (AA) and Hispanic ethnicity (HE) individuals is unclear.

121 did not have cirrhosis or advanced fibrosis; Hispanic ethnicity (OR = 12.34, 95% CI 2.59-58.82) and h

122 6; 95% confidence interval [CI], 1.20-3.54), Hispanic ethnicity (P = 0.011; OR, 6.01; 95% CI, 1.51-23

123 We found that adjusting for age, race, and Hispanic ethnicity altered the evaluation: 8 OPOs change

124 Hispanic ethnicity and an infected sibling close contact

125 sis demonstrated that neither Black race nor Hispanic ethnicity increased the chance of metastatic di

126 Hispanic ethnicity was associated with less linkage-to-c

127 of which were identified in probands of Non-Hispanic European ancestry.

128 PBDE exposures (Non-Hispanic Black > Latina/Hispanic > Non-Hispanic White > Asian/Pacific Islander/O

129 Census blocks with majority Hispanic (>60%) populations were exposed to twice as man

130 growth curves for black (B), white (W), and Hispanic (H) children for each sex.

131 d 2019 of White (W) race, Black (B) race, or Hispanic (H) ethnicity aged 18 years and older with diab

132 NHBs and Hispanics had a lower prevalence of medical barriers to

133 After multivariable adjustment, blacks/Hispanics had higher rates of cardiovascular hospitaliza

134 predominantly aged 18-29 (63.3%), white non-Hispanic, high school graduates, and not employed.

135 Maya area and the largest in the entire pre-Hispanic history of the region.

136 spitals as those with an African American or Hispanic ICU census more than twice its regional mean.

137 ically biased by an ethnonationalist view of Hispanic immigrants as a symbolic (rather than realistic

138 black/African American (n=651; AUC, 0.937), Hispanic/Latino (n=331; AUC, 0.937), and American Indian

139 Among US Hispanic/Latino adults, baseline accelerometer-derived M

140 CKD incidence varies by Hispanic/Latino heritage and this disparity may be in pa

141 These findings suggest SDB in Hispanic/Latino men and women may contribute to the burd

142 Hispanic/Latino patients had a significantly larger prop

143 Gastric cancer in Hispanic/Latino patients has unique genomic profiles tha

144 Hispanic/Latino patients have a higher incidence of gast

145 or these disparities is unknown, as very few Hispanic/Latino patients have been included in previous

146 Of the 43 Hispanic/Latino patients with diffuse-type cancer, 7 (16

147 Hispanic/Latino patients with gastric cancer possess uni

148 The most difficult Hispanic/Latino populations to retain included young, si

149 68 multi-ethnic participants (15% Black; 30% Hispanic/Latino) into 6 contiguous, physiologically dist

150 c characteristics (48% African American, 31% Hispanic/Latino, 14% white) and HIV risk varied (31% men

151 examined this association, especially in US Hispanic/Latinos, who may be at elevated risk of SDB and

152 High rates of retention of Hispanics/Latinos can be facilitated through the employm

153 Although Hispanics/Latinos in the United States are often conside

154 We aimed to examine the retention of Hispanics/Latinos participating in the Hispanic Communit

155 poral changes in population structure within Hispanics/Latinos that may influence biomedical traits,

156 ubstantial substructure and heterogeneity in Hispanics/Latinos, isolation-by-distance in African Amer

157 albumin-to-creatinine ratio in up to 12 207 Hispanics/Latinos.

158 hnic whole-genome sequencing data in admixed Hispanics/Latinos.

159 g disproportionate impact of COVID-19 on the Hispanic/Latinx (henceforth: Hispanic or Latinx) communi

160 Patients with COVID-19 were 22.3% Hispanic/Latinx and 44.2% non-White.

161 s (URGs), including Black/African Americans, Hispanic/Latinx, Pacific Islanders, and American Indians

162 on-Hispanic (NH)-White, 16% NH-Black, and 9% Hispanic/Latinx.

163 d (median age, 57 years; 44.3% female; 37.2% Hispanic/Latinx; 23.4% Black; 20.1% in the intensive car

164 NH-Whites, 4.1% for NH-Blacks, and 4.5% for Hispanics/Latinxs.

165 nd 37 +/- 6% higher NO(2) for non-whites and Hispanics living in low-income tracts (LIN) compared to

166 wer but encouraging signals for "Asian" and "Hispanic" members, and less progress for African America

167 usted incidence rates ranged from 6.6 (other Hispanic/mixed background) to 15.0 (Puerto Ricans) per 1

168 Hispanic mother-infant pairs (n = 88) were recruited acr

169 were identified including Whites (n = 241), Hispanics (n = 106), Blacks (n = 50), Asian and Pacific

170 -of-hospital cardiac arrest in predominantly Hispanic neighborhoods had lower B-CPR rates (51% to 75%

171 Compared with <25% Hispanic neighborhoods in a multivariable analysis, out-

172 are is located in low-income, non-white, and Hispanic neighborhoods.

173 Residents of non-Hispanic Black and Hispanic neighbourhoods experienced higher odds of serop

174 s, were developed using data from 17,359 non-Hispanic (NH) white, NH black, and Mexican-American NHAN

175 +/- 0.1 years, 52% were women, 75% were non-Hispanic (NH)-White, 16% NH-Black, and 9% Hispanic/Latin

176 Death rates were highest among non-Hispanic (non-H) American Indians/Alaska Natives and non

177 more likely to have good outcomes than white Hispanic/nonwhite ("Non-white") patients (34.4 vs 21.7%;

178 Hispanic (odds ratio [OR], 1.58), Asian or Pacific Islan

179 r survival rates (global P value 0.029; >75% Hispanic: odds ratio, 0.56 [CI, 0.34-0.93], P=0.023).

180 s ratio, 0.79 [CI, 0.65-0.95], P=0.014; >75% Hispanic: odds ratio, 0.72 [CI, 0.55-0.96], P=0.025) and

181 ghborhoods had lower B-CPR rates (51% to 75% Hispanic: odds ratio, 0.79 [CI, 0.65-0.95], P=0.014; >75

182 confidence interval [CI] = 0.58 to 0.78) and Hispanic or Latino (0.84; 95% CI = 0.75 to 0.94) childre

183 site, 48% in the comparison site) and/or of Hispanic or Latino ethnicity (26% in the intervention si

184 6 pregnant women (median age 29 years, 52.9% Hispanic or Latino) with CVD were seen.

185 28 patients in the placebo group; 56.0% were Hispanic or Latino, 14.9% were Black, 12.7% were America

186 21.7 to 85.4), and 45% of the patients were Hispanic or Latino.

187 COVID-19 on the Hispanic/Latinx (henceforth: Hispanic or Latinx) community in the United States, disc

188 tatistically significantly different between Hispanics or NHBs (versus NHWs).

189 ith white patients, patients who were black, Hispanic, or of another racial/ethnicity minority spent

190 ty and severe obesity stratified by race and Hispanic origin among US residents from 1999 to 2018.

191 bly classify BGA for individuals of presumed Hispanic origin.

192 Men and women in each race/Hispanic-origin group were then separated into high, med

193 to 2.96]) and higher in non-Hispanic than in Hispanic participants (for females, 11.2% versus 6.0% [O

194 ange of characteristics, younger, healthier, Hispanic participants tended to have a higher likelihood

195 chest radiography compared with White or non-Hispanic patients (adjusted average difference, 1.6; 95%

196 black patients (aOR, 0.83 [0.74-0.92]), and Hispanic patients (aOR, 0.74 [0.64-0.87]) were less like

197 l [CI]: 5.4, 6.7) compared with White or non-Hispanic patients (median score, 4.2; 95% CI: 3.6, 4.9)

198 s: After covariate adjustment, self-reported Hispanic patients (n = 290) exhibited significantly redu

199 ds of VA improvement compared with White and Hispanic patients after 1 injection (odds of 0.480, CI 0

200 For example, black, non-Hispanic patients had a higher rate of referral (hazard

201 Hispanic patients had higher rates of DR (OR, 1.60; P <

202 ine, compared with White patients, Black and Hispanic patients had lower NT-proBNP (g=0.34) and diffe

203 ilities with higher proportions of Black and Hispanic patients had significantly lower vaccination pe

204 Non-Hispanic black (NHB) and Hispanic patients have lower access to kidney transplant

205 We identified all White, Black, Asian, and Hispanic patients undergoing aortoiliac aneurysm repair

206 nstrates a reproducible survival benefit for Hispanic patients with Group 1 PAH in multiple clinical

207 for transplant-free, all-cause mortality in Hispanic patients with non-Hispanic white (NHW) patients

208 Black patients, 0.90 (95% CI, 0.73-1.11) for Hispanic patients, and 1.31 (95% CI, 0.96-1.80) for Asia

209 ith 53% of all deaths occurring in Black and Hispanic patients.

210 evacizumab treatment compared with White and Hispanic patients.

211 6% male, 31.2% non-Hispanic White, and 41.4% Hispanic patients.

212 chest radiographs compared with White or non-Hispanic patients.

213 (HR: 0.93; 95% CI: 0.88-0.98), vs white non-Hispanic patients.

214 f 4.6:1 and 3.2:1, respectively, for NHB and Hispanic persons.

215 Although the Hispanic population is the fastest-growing minority popu

216 In a high-GC-risk Hispanic population, anti-H pylori therapy had a long-te

217 cohort of an H pylori eradication trial in a Hispanic population.

218 African American/Black and Hispanic populations experience disproportionately highe

219 efore age 65 were experienced by the NHB and Hispanic populations than the NHW population-despite the

220 tressors study, a predominately lower-income Hispanic pregnancy cohort in Los Angeles, California.

221 no additional risk among younger (18-39) and Hispanic recipients.

222 over the last three decades with Blacks and Hispanics representing 7.1% and 6.3% of matriculants, re

223 at neighborhoods with a higher proportion of Hispanic residents have lower B-CPR rates and lower surv

224 dies have assessed whether the proportion of Hispanic residents in a neighborhood is associated with

225 ified by census tract based on percentage of Hispanic residents: <25%, 25% to 50%, 51% to 75%, or >75

226 75, and 0.64 for Asians, black patients, and Hispanics, respectively.

227 as higher for participants who were younger, Hispanic, Spanish-speaking, and had zero or one of the C

228 st Asian subjects as well as Amerindians and Hispanic subjects are predominantly affected by Vogt-Koy

229 2; 95% CI = 1.38 to 2.96]) and higher in non-Hispanic than in Hispanic participants (for females, 11.

230 Similarly, rate ratios for the Hispanic versus NHW population were 7.0 (95% CI 5.8, 8.7

231 racial and/or ethnic category: White or non-Hispanic versus non-White (ie, Hispanic, Black, Asian, o

232 White: OR 0.97, 95% CI 0.80-1.17, p = 0.74; Hispanic versus White: OR 0.99, 95% CI 0.73-1.34, p = 0.

233 atio [OR] 1.93, 95% CI 1.85-2.01, p < 0.001; Hispanic versus White: OR 1.84, 95% CI 1.74-1.94, p < 0.

234 NHB versus 47% in NHW) and malignancy (4% in Hispanics versus 10% in NHWs).

235 in NHBs and 43% lower (95% CI, 0.54-0.62) in Hispanics (versus NHWs) in the first year after end-stag

236 P 3 x 3-mm(2) scans in this group of healthy Hispanic volunteers.

237 d incidence rate ratios (IRRs) for black and Hispanic vs white populations in 6 cities in the United

238 We found that Hispanics were exposed to more flares despite being less

239 la but more likely to transition to a graft, Hispanics were significantly more likely to transition t

240 (Non-Hispanic Black > Latina/Hispanic > Non-Hispanic White > Asian/Pacific Islander/Other; p < 0.01)

241 al cases was higher among those who were non-Hispanic white (39 of 49 [80%] and 1104 of 1818 [61%], r

242 on, PrEP patients were more likely to be non-Hispanic white (45% versus 26.2%), older (25% versus 19%

243 female (77.4%, 80.7%, respectively) and non-Hispanic white (68.5%, 59.4%, respectively).

244 age, 35 vs 46 years), more likely to be non-Hispanic white (81% vs 56%), and had longer hospitalizat

245 Most were Non-Hispanic White (86.3%) and had a college degree (64.3%).

246 ck), 14.9% were Hispanic, and 62.4% were non-Hispanic White (from here referred to as White).

247 in a separate testing cohort (n=52 870): non-Hispanic white (n=44 524; area under the curve [AUC], 0.

248 ause mortality in Hispanic patients with non-Hispanic white (NHW) patients as the reference group.

249 carcinoma in specific anatomic sites for non-Hispanic White (NHW), non-Hispanic Black, Hispanic, and

250 s Affairs; most (91%) were men, 74% were non-Hispanic White (White), 19% were non-Hispanic Black (Bla

251 ikely among non-Hispanic Black adults vs non-Hispanic White adults (41.5% vs 48.2%, respectively; mul

252 nd 25 939 (50.1%) were women; 43.2% were non-Hispanic White adults; 21.6%, non-Hispanic Black adults;

253 13,742,486 (53.6%) participants were of non-Hispanic white ancestry, 5,971,598 (23.3%) of Hispanic a

254 prospectively compare the capacity of a non-Hispanic white cohort, stratified by FADS genotype at th

255 ) had fewer outpatient visits than their non-Hispanic white counterparts.

256 Two novel risk loci for SCCHN in non-Hispanic white individuals highlight the importance of i

257 trations.Methods: DNA samples from 1,693 non-Hispanic white individuals, 385 African Americans, and 9

258 26.1%) (median age, 63.2 years) and 6446 non-Hispanic White men (73.9%) (median age, 65.5 years), and

259 alth Care System of African American and non-Hispanic White men diagnosed with low-risk prostate canc

260 Among African American men and non-Hispanic White men, respectively, the 10-year cumulative

261 compared with residents of predominantly non-Hispanic white neighbourhoods.

262 vine versus (68)Ga-PSMA-11 compared with non-Hispanic White patients (odds ratio, 3.88; 95% CI, 1.90-

263 6-1.80) for Asian patients compared with non-Hispanic White patients.

264 pulations experience similar outcomes to non-Hispanic White populations (low-strength evidence).

265 re flares despite being less likely than non-Hispanic White residents to live near unconventional oil

266 e assayed genome-wide DNA methylation in non-Hispanic white smokers with and without chronic obstruct

267 dentified African American subjects than non-Hispanic white subjects in GERA (4.4% vs 2.1%; odds rati

268 and have a higher risk of mortality than non-Hispanic White women.

269 tion (derivation cohort, n=44 959; 96.2% non-Hispanic white) demonstrated consistent performance to d

270 Non-Hispanic black (versus non-Hispanic white) race/ethnicity was associated with highe

271 5 [50%] female students; 1880 [56%] were non-Hispanic white), 32% were low-income, 12% were low-middl

272 rs; 1529 of 1993 participants [77%] were non-Hispanic white).

273 ents, 51.7% identified as male, 62.1% as non-Hispanic white, 17.4% as non-Hispanic black, and 14.6% a

274 ican Indian or Alaska Native, 12.7% were non-Hispanic White, and 3.7% were of other or unknown race o

275 f 955 survivors, 54% were male, 66% were non-Hispanic White, and 36% had leukemia.

276 ge was 59.8 years with 53.6% male, 31.2% non-Hispanic White, and 41.4% Hispanic patients.

277 NPs in 2,171 cases and 4,493 controls of non-Hispanic white, of which, 434,839 typed and 7,423,250 im

278 c Black, 6.3% were Asian, and 35.2% were non-Hispanic White.

279 in the African-American (AA) compared to non-Hispanic white.

280 te, had a family history of HNC, and was non-Hispanic white.

281 for people age 65+ years), and 70% were non-Hispanic white.

282 sceptibility were age group 30-49 years, non-Hispanic white/black, 130% above the poverty level, and

283 White non-Hispanic ("White") patients were more likely to have goo

284 r, the study population comprised mostly non-Hispanic whites (1153 patients, 74%), so the primary ana

285 on-Hispanic blacks (13.6%) compared with non-Hispanic whites (25.8%; adjusted prevalence ratio: 0.63

286 persisted for non-Hispanic Blacks versus non-Hispanic Whites (mean annual decrease 2.3% versus 2.6%,

287 ss to kidney transplantation compared to non-Hispanic whites (NHWs).

288 but the findings, mostly from studies of non-Hispanic whites and Asians, are inconsistent.

289 assifier), and a network trained only in non-Hispanic whites from the original derivation cohort perf

290 on-Hispanic blacks (P-trend < .001), but non-Hispanic whites had higher rates of MBS utilization (45.

291 to be lower in African Americans than in non-Hispanic whites, but whether adding information on parat

292 r non-Hispanic Blacks in comparison with non-Hispanic Whites.

293 e individuals, 385 African Americans, and 90 Hispanics with >=20 pack-years smoking were resequenced

294 from Black non-Hispanic (BNH) and White non-Hispanic (WNH) women.

295 The greatest declines were among Hispanic women (odds ratio of awareness comparing 2019 t

296 Black women (OR = 1.58, 95% CI: 1.49, 1.69), Hispanic women (OR = 1.15, 95% CI: 1.05, 1.25), women wi

297 We examined Hispanic women from the longitudinal Southern California

298 women compared to the referent group (Latina/Hispanic women).

299 at was mediated was 7% in Black women, 6% in Hispanic women, and 5% in other women.

300 ck women, RR = 1.23, 95% CI: 1.18, 1.28; for Hispanic women, RR = 1.05, 95% CI: 1.02, 1.09).